HbA1c Rapid Quantitative Test
- UID
- IMP/IVD/2022/000074_83cfafd97de1c476342478e3b83f1089_50fd5a818b73691059e9a68f8ad12243
- Device class
- Class B
- Brand name
- Glycated Hemoglobin
- License holder
- FINOVA HEALTHCARE PRIVATE LIMITED
- Approving authority
- CDSCO
- Product information
- The Aehealth HbA1c Rapid Quantitative Test along with Aehealth Fluorescence Immunoassay Analyzer (Glycated Hemoglobin) is intended for vitro quantitative determination of HbA1c in human blood
HbA1c Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000074_83cfafd97de1c476342478e3b83f1089_50fd5a818b73691059e9a68f8ad12243. This device is marketed under the brand name Glycated Hemoglobin. The license holder is FINOVA HEALTHCARE PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.